2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- Wall Street ends higher as US, Iran attacks ease; major tech-related shares jump
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
Amedisys (AMED) PT Raised to $60 at Baird Following 3Q
November 10, 2017 8:56 AM ESTBaird raised its price target on Amedisys (NASDAQ: AMED) to $60.00 (from $50.00) while maintaining a Neutral rating following the company's 3Q release. 3Q17 revenues of $386.7m beat consensus of $385.3m by 0.4%. EBITDA of $36.9m beat consensus of $35.5m by 3.9% and EPS of $0.56 exceeded consensus at $0.53... More
